Posted 5 days ago
Cancer Care & Prevention Symposium 2025
Thank you to everyone who attended the Cancer Care & Prevention Symposium 2025, presented by Ironwood Cancer &…
Category: Prostate Cancer
Posted 2 years ago
FDA approves talazoparib with enzalutamide for HRR gene-mutated metastatic castration-resistant prostate cancer.
Ironwood Cancer & Research Centers are committed to the advancement of medical knowledge and patient care. Medical research…
Posted 5 years ago
Hereditary Prostate Cancer: What You Need To Know
Prostate cancer is one of the most prevalent cancer types in men. Although the cause of this common…